Novo Nordisk on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and development, to.
Eli Lilly & Co. is best positioned to dominate the fast-growing U.S. market for obesity drugs into the 2030s, BMO Capital Markets analysts said in a report.